China, one of the countries affected by the new tariffs, is the world’s largest producer of active pharmaceutical ingredients ...

Union Minister of State for Health and Family Welfare, Anupriya Patel, delivered the keynote address at the 15th ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

Market uncertainty makes investors nervous about investing in speculative industries. But Wall Street has high hopes for ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

United Airlines has purchased all the capacity on a northbound cargo service from Puerto Rico to Chicago operated by Global ...

The 340B Drug Pricing Program allows certain hospitals and clinics to buy medications given to outpatients at a discount, ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Amid the federal funding uncertainty for health and sciences, local life science leaders say this could be a moment for industry partners, investors and others to step up and support the sector.

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...